Table 1.
Pancreatic disease entities and the severity of pain n (%)
| Diagnosis | Pain |
P value | ||
| Pain 0 | Pain I | Pain II | ||
| Pancreatic cancer | 211 | 154 | 65 | < 0.0001 |
| (49.0) | (35.8) | (15.1) | ||
| Chronic pancreatitis | 54 | 140 | 101 | |
| (18.3) | (47.5) | (34.2) | ||
| Serous cystadenoma | 18 | 12 | 1 | < 0.02 |
| (58.0) | (38.7) | (3.2) | ||
| Mucinous cystadenoma | 4 | 11 | 4 | |
| (21.0) | (57.9) | (21.0) | ||
| Non-invasive IPMN | 19 | 20 | 2 | 0.235 |
| (46.3) | (48.8) | (4.9) | ||
| Invasive IPMN | 11 | 18 | 5 | |
| (32.4) | (52.9) | (14.7) | ||
| Low stage neuroendocrine neoplasia | 9 | 5 | 0 | 0.565 |
| (64.3) | (35.7) | (0.0) | ||
| High stage neuroendocrine neoplasia | 23 | 13 | 3 | |
| (59.0) | (33.3) | (7.7) | ||
| AmpC | 27 | 13 | 4 | |
| (61.4) | (29.6) | (9.1) | ||
| Total | 322 | 246 | 84 | |
| (49.4) | (37.7) | (12.9) | ||
IPMN: Intraductal papillary mucinous neoplasia.